Breathe Life Sciences (BXN:ASX) is an Australian multi-national life sciences company focused on research, development, manufacture, and wholesale of novel pharmaceuticals, medicinal cannabis, psilocybin, consumer health and lifestyle products. In 2023 BLS was acquired by Bioxyne (BXN:ASX). The merged group has head offices in Sydney, London, Prague, and Nagoya. The Company operates in Australia, the United Kingdom, Germany, France, Czechia, Japan, and the United States. https://bioxyne.com/